Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

2,425.00p
   
  • Change Today:
    -68.00p
  • 52 Week High: 2,575.00
  • 52 Week Low: 1,593.00
  • Currency: UK Pounds
  • Shares Issued: 243.17m
  • Volume: 704,169
  • Market Cap: £5,897m
  • RiskGrade: 214

Latest ShareCast News

Hikma gets FDA approval for generic version of 'Vascepa'

By Josh White

Date: Friday 22 May 2020

(Sharecast News) - Hikma Pharmaceuticals announced on Friday that its wholly-owned US subsidiary has received approval from the US Food and Drug Administration (FDA) for its icosapent ethyl capsules at one gram, which is its generic equivalent to 'Vascepa'.

HIK Regulatory News

Total Voting Rights 02-Jun-2020 09:31 RNS
Hikma receives FDA approval for generic Vascepa&... 22-May-2020 07:00 RNS
Director/PDMR Shareholding 20-May-2020 15:42 RNS
Director/PDMR Shareholding 13-May-2020 13:28 RNS
Total Voting Rights 01-May-2020 11:30 RNS

HIK News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HIK Market Data

Currency UK Pounds
Share Price 2,425.00p
Change Today -68.00p
% Change -2.73 %
52 Week High 2,575.00
52 Week Low 1,593.00
Volume 704,169
Shares Issued 243.17m
Market Cap £5,897m
RiskGrade 214

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.99% below the market average92.99% below the market average92.99% below the market average92.99% below the market average92.99% below the market average
60.71% below the sector average60.71% below the sector average60.71% below the sector average60.71% below the sector average60.71% below the sector average
Price Trend
91.36% above the market average91.36% above the market average91.36% above the market average91.36% above the market average91.36% above the market average
75.44% above the sector average75.44% above the sector average75.44% above the sector average75.44% above the sector average75.44% above the sector average
Income
81.74% below the market average81.74% below the market average81.74% below the market average81.74% below the market average81.74% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
44.65% above the market average44.65% above the market average44.65% above the market average44.65% above the market average44.65% above the market average
94.44% above the sector average94.44% above the sector average94.44% above the sector average94.44% above the sector average94.44% above the sector average

What The Brokers Say

Strong Buy 6
Buy 1
Neutral 4
Sell 2
Strong Sell 1
Total 14
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Final Interim
Ex-Div 19-Mar-20 22-Aug-19
Paid 07-May-20 23-Sep-19
Amount 30.00¢ 14.00¢

Trades for 02-Jun-2020

Time Volume / Share Price
16:47 6,885 @ 2,439.51p
16:35 212,324 @ 2,425.00p
16:29 41 @ 2,425.00p
16:29 20 @ 2,424.00p
16:29 37 @ 2,425.00p

HIK Key Personnel

CEO Sigurdur Olafsson

Top of Page